• FK866 (APO866): Optimizing NAMPT Inhibition in AML Research

  2026-08-04

  FK866 (APO866) stands out as a highly selective NAMPT inhibitor for dissecting NAD metabolism and non-apoptotic cell death in hematologic cancer research. This guide details experimental workflows, troubleshooting strategies, and translational insights, with emphasis on acute myeloid leukemia (AML) and immune-metabolic applications.

• EZ Cap™ Firefly Luciferase mRNA: Optimized Reporter Assay Wo

  2026-08-04

  EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure delivers sensitive, sustained bioluminescent reporting for gene regulation, translation efficiency, and in vivo imaging workflows. This article dissects advanced use-cases, protocol enhancements, and troubleshooting strategies—integrating the latest innovations in mRNA delivery and oxidative stress mitigation for superior assay outcomes.

• AptaBLE: Deep Learning for Aptamer-Protein Interaction Desig

  2026-08-03

  AptaBLE introduces a cross-attention deep learning framework to predict and generate aptamer–protein binding interactions with high accuracy. By addressing limitations of SELEX and prior computational tools, this platform accelerates the discovery of aptamers for therapeutic and diagnostic applications.

• CFTRinh-172: Precision CFTR Inhibition for Epithelial Ion Tr

  2026-08-03

  Discover how CFTRinh-172, a highly selective CFTR inhibitor, advances cystic fibrosis research and secretory diarrhea models. This article offers deep mechanistic analysis and practical guidance for assay optimization.

• E-64 (SKU A2576): Precision Cysteine Protease Inhibition in

  2026-08-02

  This article provides scenario-driven guidance for leveraging E-64 (SKU A2576), a potent L-trans-epoxysuccinyl peptide inhibitor, to address key challenges in cell viability, proliferation, and cytotoxicity assays. Drawing from peer-reviewed literature and data, it outlines reliable protocols, addresses common troubleshooting points, and compares vendor reliability for cysteine protease inhibition workflows.

• MK-571 (L-660,711): Precision Leukotriene D4 Receptor and MR

  2026-08-01

  MK-571 (L-660,711) is a potent, selective antagonist of the leukotriene D4 (LTD4) receptor and a validated MRP1 inhibitor. It enables highly reproducible research in inflammation, asthma, and multidrug resistance. The compound exhibits nanomolar affinity and robust in vivo activity, as confirmed in animal and cellular models.

• Marein Restores Chemosensitivity by Inhibiting ABCG2 Transpo

  2026-07-31

  The referenced study identifies marein, a flavonoid from Coreopsis tinctoria, as a competitive inhibitor of the ABCG2 transporter. This mechanism restores chemosensitivity to multidrug-resistant cancer cells, including those resistant to mitoxantrone, and has significant implications for developing combination therapies to overcome resistance in oncology models.

• 5-Aminolevulinic Acid HCl: Redefining Heme Biosynthesis Assa

  2026-07-31

  Discover how 5-Aminolevulinic acid HCl revolutionizes precise modeling of bacterial heme biosynthesis and immune evasion. This in-depth analysis explores advanced assay design, translational research impact, and practical protocol guidance.

• EPI-001: Androgen Receptor N-Terminal Domain Inhibitor Workf

  2026-07-30

  EPI-001 redefines androgen receptor targeting by disrupting both full-length and splice variant AR, offering unique advantages for prostate and triple-negative breast cancer research. Its N-terminal mechanism unlocks experimental flexibility and robust pathway inhibition not achievable with traditional ligand-binding inhibitors.

• Tacrolimus (FK506): Precision Immune Modulation in Research

  2026-07-30

  Tacrolimus (FK506) delivers high-potency, selective calcineurin inhibition ideal for dissecting T-cell activation, cytokine signaling, and transplantation immunology. This guide distills advanced workflows, protocol enhancements, and troubleshooting insights to maximize reproducibility and impact in immune modulation studies.

• Protease Inhibitor Cocktail (100X H₂O, EDTA Plus): Enabling

  2026-07-29

  Explore how the Protease Inhibitor Cocktail (100X H₂O, EDTA Plus) empowers advanced lipid droplet research by preserving protein integrity in complex cellular workflows. This article reveals unique assay optimizations and scientific insights, building on emerging discoveries in DFCP1-ATGL metabolism.

• Hydroxychloroquine Sulfate: Technical Guide for Autoimmune R

  2026-07-29

  Hydroxychloroquine Sulfate (SKU B4874) provides a reliable tool for researchers investigating autophagy inhibition and toll-like receptor signaling in autoimmune disease models. Its defined solubility and stability profile make it suitable for aqueous, short-term protocols but unsuitable for workflows requiring organic solvents or long-term solution storage.

• LY294002 in Translational Research: Mechanistic Power, Strat

  2026-07-28

  Explore how LY294002, a potent PI3K/Akt/mTOR signaling pathway inhibitor, advances translational discovery by bridging mechanistic insight with practical strategy. This article integrates recent experimental findings, emphasizes protocol precision, and positions APExBIO’s LY294002 as a foundational tool—moving beyond conventional summaries to offer guidance for researchers in cancer, autophagy, and inflammatory disease models.

• Protease Inhibitor Cocktail (EDTA-Free): Mechanism & Researc

  2026-07-28

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) is a protein stability enhancer that inhibits multiple protease classes during cell and tissue extraction. It enables reliable preservation of proteins for OXPHOS and immunoassay workflows. This article details its mechanism, evidence, and integration into advanced research protocols.

• Lysoptosis: An Evolutionarily Conserved Cell Death Pathway

  2026-07-27

  This article examines the recent discovery and characterization of lysoptosis, a regulated cell death pathway driven by lysosomal membrane permeabilization and cathepsin release, as reported by Luke et al. The study's comparative analysis across C. elegans, mouse, and human models provides new insight into the evolutionary conservation and mechanistic specificity of lysoptosis, with implications for research in apoptosis, neuroprotection, and cancer biology.

16153 records 1/1077 page Next 12345 下5页 Last page